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The β2–α2 loop of PrPC is a key modulator of disease-associated prion protein misfolding. Amino 
acids that differentiate mouse (Ser169, Asn173) and deer (Asn169, Thr173) PrPC appear to confer 
dramatically different structural properties in this region and it has been suggested that amino acid 
sequences associated with structural rigidity of the loop also confer susceptibility to prion disease. 
Using mouse recombinant PrP, we show that mutating residue 173 from Asn to Thr alters protein 
stability and misfolding only subtly, whilst changing Ser to Asn at codon 169 causes instability in 
the protein, promotes oligomer formation and dramatically potentiates fibril formation. The doubly 
mutated protein exhibits more complex folding and misfolding behaviour than either single mutant, 
suggestive of differential effects of the β2–α2 loop sequence on both protein stability and on specific 
misfolding pathways. Molecular dynamics simulation of protein structure suggests a key role for the 
solvent accessibility of Tyr168 in promoting molecular interactions that may lead to prion protein 
misfolding. Thus, we conclude that ‘rigidity’ in the β2–α2 loop region of the normal conformer of PrP 
has less effect on misfolding than other sequence-related effects in this region.
Transmissible spongiform encephalopathies (TSEs), also known as prion diseases, are neurodegenerative 
diseases that include Creutzfeldt-Jakob disease, scrapie, bovine spongiform encephalopathy and chronic 
wasting disease (CWD). TSE disease is characterised by the formation of proteinaceous deposits com-
posed of a misfolded form (PrPSc) of the cellular prion protein, PrPC. It is widely believed that PrPSc 
carries with it enough information encoded in its structure to initiate disease in naïve individuals after 
experimental inoculation1,2. The prion protein is the product of the PRNP gene and comprises roughly 
250 amino acids, depending on species. The mature protein carries a C-terminal glycosylphosphatidy-
linositol membrane anchor, two N-linked carbohydrate chains and a single disulphide bond. The NMR 
structure of PrPC shows that the mature N-terminal domain (residues 23 to ~120) of the protein is 
flexibly-disordered and contains poly-L-proline conformational elements3,4, whilst the C-terminal region 
(residues ~121 to 231) consists of 3 α -helices and two short β -strands5,6. Figure 1 displays many of these 
structural features schematically. When PrPC misfolds into PrPSc, there is a dramatic increase in β -sheet 
structure at the expense of helical structure7 and the resultant protein becomes partially resistant to 
proteolytic digestion. Crucially, post-translational modifications appear similar between PrPC and PrPSc, 
suggesting that the conversion process is purely conformational2,8.
Alterations to specific amino acids of PrPC, both within and between species, can impact on the 
course of TSE disease. For instance, differences in specific residues between species are believed partly 
to underlie species barrier effects in disease transmission9,10, whilst coding polymorphisms in the PRNP 
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gene in humans and animals have been linked to susceptibility to acquired TSE infections11,12. Many 
studies have sought to define differences in structural properties of recombinant PrP (recPrP) carrying 
amino acid changes relative to the wildtype counterparts, but there exists poor overall consensus on 
how specific amino acid changes affect mechanisms of protein misfolding. In recent years, attention has 
focussed on a key structural loop of PrPC located between β -sheet 2 and α -helix 2 (see Fig. 1)13–22. This 
interest was initiated following the publication of NMR data suggesting that the β 2–α 2 loop of cervid 
PrPC was particularly well defined relative to that of other mammalian species. Cervid and other prion 
proteins, for which the loop structure could be defined, were thus given the designation ‘rigid loop’ PrP23 
and it was suggested that the structures of non-rigid β 2–α 2 loops could not be defined because rapid 
conformational exchange caused NMR peak broadening. Gossert et al. confirmed that the ‘rigid loop’ 
phenotype of the β 2–α 2 loop in cervid PrPC was caused by residues 169 and 173 (murine numbering, 
which will be used from this point forward)23. However, more recent data has suggested that ‘rigid loop’ 
prion proteins are actually undergoing extremely rapid conformational interconversion between two 
discrete states, such that an average structure is being measured by NMR24. The implication is thus that 
‘rigid loop’ PrP molecules are actually more conformationally labile than non-‘rigid loop’ proteins, but 
the definition of a ‘rigid loop’ still differentiates prion proteins whose loop conformation is resolved by 
NMR at 20 °C from those that aren’t.
Chronic wasting disease is a TSE of deer and elk that shows high natural transmissibility25. Since 
cervid PrPC possesses ‘rigid loop’ properties, it has been suggested that a rigid β 2-α 2 loop may explain 
the high susceptibility of cervids to CWD14. To investigate mechanistically whether a ‘rigid loop’ causes 
biophysical changes in PrP that may impact on disease, we have investigated the stability and misfold-
ing pathways of wildtype murine recPrP (recMoPrP), which is not a ‘rigid loop’ structure, as well as 
a murine recPrP containing the deer-specific amino acids at codons 169 and 173 (recMoPrP-S169N/
N173T), which has been shown to exhibit ‘rigid loop’ behaviour23. Two additional recombinant proteins 
were produced in which single amino acid changes were made (recMoPrP-S169N, a ‘rigid loop’ mole-
cule26, and recMoPrP-N173T, a non-‘rigid loop’ molecule23). The data produced do not support a role for 
loop rigidity in mediating misfolding per se, but instead indicate a complex interplay between stability 
and the different misfolding pathways underpinned by variable solvent exposure of Tyr168.
Results
We have previously demonstrated that combined in vitro and in silico studies can be used to understand 
the structural and functional effects of amino acid changes at codon 164 in murine PrP27,28. Residue 
164 is adjacent to the β 2–α 2 loop region (Fig. 1) and in the current study we investigate cervid-specific 
amino acid substitutions in this region, specifically at residues 169 and 173. The 4 protein variants were 
expressed, purified and the integrity of each was checked routinely by SDS-PAGE, mass spectrometry 
Figure 1. Schematic diagram of structural features of mammalian prion proteins (top). Sequence 
numbering is per the murine protein. Also depicted is an alignment of the sequences of important 
mammalian prion proteins in the β 2–α 2 loop region—sequence numbering on this part of the figure is 
precise and is taken from the protein sequences of each individual species. Boxes with solid lines represent 
the key amino acid differences between deer/elk and other species whilst the dashed box represents the 
polymorphic position in sheep that segregates with susceptibility to prion disease infection.
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and circular dichroism spectropolarimetry. There were minor differences in the far-UV CD spectra of 
the four protein variants (Supplementary Fig. 1), which may suggest minor variations in the amount of 
tertiary structure present, but qualitatively all show the characteristic double minima at 222 and 208 nm 
indicative of protein with a high level of helical structure. We therefore used our proteins to investigate 
the differences in protein stability and misfolding caused by the cervid mutations by use of a range of 
biochemical and biophysical techniques, thereby allowing us to truly assess whether β 2–α 2 loop confor-
mation dictates protein stability.
The S169N substitution dramatically affects protein fibrillisation, but its effect is potentiated 
by co-inclusion of the N173T substitution. Firstly we investigated the effect that the amino acid 
changes had on fibrillisation of the proteins (Figs 2 and 3). Fibrillisation was monitored by ThT fluores-
cence and, to allow comparisons between proteins, background fluorescence was removed and the result-
ing signals normalised. In our buffer system, fibrillisation is characterised by a lag phase, during which 
a nucleus of misfolded protein forms, followed by an exponential elongation phase until most protein is 
contained within fibrils and the trace plateaus. Addition of a pre-formed seed typically shortens the lag 
phase by by-passing the nucleation event. Representative fibrillisation traces are given in Fig. 2 whilst bar 
charts depicting average lag times and elongation rates, for at least 18 experimental repeats, are shown 
in Fig. 3. Figure 3 also incorporates relevant student’s t-tests. For all protein variants, we demonstrated 
that increases in ThT fluorescence indicated fibril formation by confirming the presence of a 17 kDa 
proteinase K resistant species following maturation (Supplementary Fig. 2), a property that is indicative 
of bona fide fibrils formed from recombinant PrP29.
RecMoPrP fibrillised rapidly with a lag time of ~2 hours (Fig. 3(A)), as published previously30, which 
was shortened slightly by adding pre-formed fibrils to seed the reaction. By contrast, recMoPrP-S169N 
had an extended lag phase to fibrillisation, which was also reduced by addition of pre-formed seed, 
although the lag phase of seeded reactions of recMoPrP-S169N were still substantially longer than those 
of recMoPrP. Lag phases for recMoPrP-N173T, both with and without seed, were also increased relative 
to recMoPrP, but the differences were small, whilst recMoPrP-S169N/N-173T had lag phases that were 
intermediate between the two singly-mutated proteins.
Considering the elongation phase of fibrillisation, recMoPrP had the highest elongation rates, and 
those of recMoPrP-N173T were similar. By contrast, both recMoPrP-Sn169 and recMoPrP-S169N/
N173T had elongation rates that were reduced relative to recMoPrP and recMoPrP-N173T. Thus, over-
all, the N173T substitution does not dramatically affect fibrillisation whilst the S169N substitution slows 
both nucleation and elongation. When both mutations are present in the same protein, fibrillisation 
properties are intermediate between the two single mutants. From these studies it appears that the two 
proteins that have the ‘rigid loop’ phenotype are poor substrates for misfolding but we wanted to confirm 
this conclusion using an alternate misfolding assay.
The doubly mutated protein, recMoPrP-S169N/N173T, oligomerises more rapidly and pro-
duces more high molecular weight oligomers than other proteins. We next investigated a 
misfolding pathway that results in comparatively low molecular weight, oligomeric species and that is 
driven primarily by reduced pH27,31. The extent of oligomerisation was monitored by size exclusion chro-
matography and typical sets of data for each of the 4 protein variants are shown in Fig.  4  (A–D). For 
recMoPrP (Fig.  4(A)), the peak corresponding to monomeric protein, eluting at 11.5 minutes (labelled 
P3), gradually reduced in intensity over the reaction, whilst a new peak eluting at ~9 minutes (labelled 
P2) increased in intensity. Previously, this peak has been shown to correspond to oligomers of roughly 
300 kDa (around 12-meric), whilst a shoulder on this peak at 8 minutes (labelled P1) represents a still 
higher molecular weight form composed of ~36 monomer units31. The peak at 12.5 mins corresponds to 
the total volume of the column and is caused by variations in salt concentration.
Oligomerisation profiles of each of the proteins show similar features but quantitative differences, 
hence we repeated the analyses at least 6 times for each proteins and calculated the average percentage 
of each molecular species. This allowed curves to be fitted to the data according the reaction scheme 
given in Supplementary Materials (Fig.  4  (E–H)). It should be born in mind that there was a delay of 
up to 10 minutes between preparing the oligomerisation reaction and performing the first SEC analysis, 
hence the x-axes in these charts are actually offset compared to the time after sample preparation. This 
offset explains why “time zero” samples already contain significant amounts of oligomers and why the 
prevalence of oligomers in the starting samples correlates with the speed of oligomerisation. The fitting 
procedure allowed for variations in the time it took to prepare samples and this allowed us to extract 
rate constants for the reactions that yield the small (k1) or large (k2) oligomers, which are displayed on 
Fig. 4. An associated table (Supplementary Table 1) contains details of where differences in rate constants 
are statistically significant.
Oligomerisation profiles for recMoPrP-N173T (Fig.  4(C)) are similar to those for recMoPrP, and 
the rates of oligomer formation for these proteins are not statistically different. recMoPrP-S169N oli-
gomerises more rapidly than recMoPrP and differences in k1 are statistically significant (Supplementary 
Table 1). In contrast to the other 3 proteins, recMoPrP-S169N/N173T (Fig. 4(D)) lost monomer from the 
oligomerisation reaction rapidly and increasing amounts of the larger oligomer, P1, eluting at 8 minutes, 
were produced at the expense of the smaller oligomer, P2. However, oligomerisation profiles were rather 
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variable and, whilst differences in k1 relative to recMoPrP are statistically significant, those in k2 are 
not. Overall, the recMoPrP-S169N and recMoPrP-S169N/N173T protein oligomerized significantly more 
rapidly than the wildtype recMoPrP (differences in k1 are significant, p < 0.05) suggesting that a ‘rigid 
loop’ phenotype predisposes the protein to misfolding. This conclusion is the opposite to that obtained 
for fibrillisation but actually concurs with similar observations that we made for proteins that varied at 
codon 16427.
Figure 2. Representative profiles of ThT fluorescence as a function of fibrillisation time for reactions 
involving (A) and (E) wildtype recMoPrP; (B) and (F) recMoPrP-S169N; (C) and (G) recMoPrP-N173T; 
(D) and (H) recMoPrP-S169N/N173T. Reactions depicted in panels (E–H) included the addition of 
preformed fibrils at time zero, whilst those in panels (A–D) were unseeded. Triplicate fibrillisation reactions 
were monitored for 24 hours with fluorescence readings taken every 5 minutes and plotted as points (Δ ,ο ,x) 
to which sigmoidal curves were fitted (solid lines).
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The S169N substitution reduces thermal stability, but its effect is reversed by concomitant 
N173T substitution. For recPrP mutants that differed at amino acid 164, we previously identified a 
correlation between resistance to thermal denaturation and the ability of protein variants to convert into 
disease-relevant misfolded isoforms27. In vitro oligomerisation proceeded more rapidly for thermally 
stable proteins, whilst in vitro fibrillisation was less rapid for thermally-stable proteins28. To determine 
whether differential thermal stability could contribute to the alteration in fibrillisation and oligomer-
isation rates between the current protein variants, we used circular dichroism to determine how the 
proportion of protein that was unfolded varied with temperature. At least 4 experimental replicates were 
done for each variant and the average of these data is shown in Fig. 5. The significance of differences in 
the midpoints of the thermal transitions was tested using Student’s t-test.
Similar to the oligomerisation data, the thermal denaturation profiles for the doubly-mutated protein, 
recMoPrP-S169N/N173T were more variable than those for the other protein variants, but nevertheless, 
this protein was significantly more thermally stable than either recMoPrP or recMoPrP-S169N. The mid-
point of the thermal transition of recMoPrP-N173T was not significantly different from recMoPrP, whilst 
Figure 3. Graphs of quantitative parameters extracted from fitted fibrillisation curves for the 4 protein 
variants both without and with addition of preformed seed to drive the reaction. (A) is a bar chart 
depicting the average lag time to fibrillisation whilst (B) represents the average rate of fibrillisation. Error 
bars are standard deviations and represent n > = 18 reactions for each variant. T-Test statistics (inset tables) 
test differences between lag times (A) or elongation rates (B).
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recMoPrP-S169N was significantly less stable than the wildtype protein. Therefore, in line with our pre-
vious studies, an increase in thermal stability of recMoPrP-S169N/N173T relative to recMoPrP correlates 
with a reduction in fibrillisation kinetics but an increase in oligomerisation kinetics, whilst there are no 
significant differences in thermal stability of recMoPrP-N173T and recMoPrP and their oligomerisation 
and fibrillisation profiles were also similar. However, the thermal destabilisation of recMoPrP-S169N 
Figure 4. Oligomerisation of the murine PrP variants. Panels (A–D) represent typical size exclusion 
chromatograms over a time course of oligomerisation of (A) recMoPrP; (B) recMoPrP-S169N; (C) 
recMoPrP-N173T; (D) recMoPrP-S169N/N173T. Samples were incubated at 45 °C in oligomerisation buffer 
and aliquots were removed from the reaction every 15 minutes from 0 (lightest trace) to 105 minutes 
(darkest trace) for analysis. Oligomerisation was performed at least 4 times for each variant, the area under 
each peak was calculated and plotted as a function of time for (E) recMoPrP; (F) recMoPrP-S169N; (G) 
recMoPrP-N173T; (H) recMoPrP-S169N/N173T. •–peak 1 (large oligomer) ■–peak 2 (small oligomer)  
▲–peak 3 (monomeric protein). Error bars represent the standard deviations.
www.nature.com/scientificreports/
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Figure 5. Thermal denaturation profiles of recombinant PrP variants as monitored by circular 
dichroism spectropolarimetry at 222 nm. The normalised ellipticity at 222 nm is plotted against 
temperature and a sigmoidal curve fitted. Error bars are standard deviations from n > = 5 replicate analyses. 
T-Test statistics test differences between midpoints of each curve.
Figure 6. The unfolding transition of PrP variants in the presence of urea at pH 7 (◆) and pH 4 (■) at 
a concentration of 5 μM. The ellipticity at 222 nm was monitored by circular dichroism, normalised, and 
the average of 3 readings were plotted against the increasing concentration of urea. A curve representing a 
bi-phasic transition was fitted to each set of data to allow the calculation of midpoints of the transitions (A) 
recMoPrP; (B) recMoPrP-S169N; (C) recMoPrP-N173T; (D) recMoPrP-S169N/N173T.
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relative to recMoPrP was unexpected in light of the fibrillisation and oligomerisation data. We therefore 
sought an alternative assay to assess the relative stability of the different protein variants.
RecMoPrP-S169N and recMoPrP-S169N/N173T are more susceptible to urea-based denatur-
ation than recMoPrP or recMoPrP-N173T. Monitoring the circular dichroism spectrum of recPrP 
as a function of urea concentration has previously allowed the identification of β -structured intermedi-
ates in the unfolding pathway32. We used urea-based denaturation to study the unfolding transition of 
our protein variants and the data are plotted graphically in Fig. 6. Each data point is the average of three 
experimental replicates but a single sigmoidal curve has been fitted through the average of the data for 
each protein variant, assuming a two state unfolding reaction. Although this process allowed the extrap-
olation of the midpoint of the unfolding transition in each case, the fit to the data was poor, since there 
are intermediates in the unfolding transition, hence we restrict ourselves to a qualitative interpretation 
of these data.
Urea-mediated unfolding was studied at two different pH values and these were chosen such that 
the higher pH was close to that used during thermal denaturation and fibrillisation studies, whereas 
the lower pH was close to that used during the oligomerisation experiments. Since unfolding interme-
diates had previously been identified at reduced pH using similar methodology, we included additional 
data points at pH 4.0 to allow us to discern such intermediates, if they were present. At both pH 4.0 
and 7.0, all recPrP proteins produced urea denaturation profiles which were essentially sigmoidal, as 
shown in Fig.  6, but which differed in terms of the midpoints of the unfolding transitions. At pH 7, 
recMoPrP and recMoPrP-N173T produced denaturation curves that were centred on ~5.9 M urea. By 
contrast, the unfolding of recMoPrP-S169N and recMoPrP-S169N/N173T had midpoints at ~5.5 M and 
~5.3 M, respectively. At pH 4.0, midpoints of the transitions for recMoPrP and recMoPrP-N173T were 
again similar (~4.4 M and ~4.3 M respectively), whilst the midpoints of the unfolding transitions for 
recMoPrP-S169N and recMoPrP-S169N/N173T were reduced to ~4.0 M urea.
The data at pH 4, depicted in Fig. 6, also indicate the presence of unfolded intermediates for all proteins 
studied, as evidenced by plateaus in the unfolding transitions (arrowed in Fig. 6(A)). Although several such 
plateaus may exist, the most obvious plateau for recMoPrP, recMoPrP-N173T and recMoPrP-S169N/N173T 
occurred at ~5 M urea, whilst for recMoPrP-S169N this plateau occurred at ~4.5 M urea. Thus, taken 
together, these data indicate that both recMoPrP-S169N and recMoPrP-S169N/N173T are more 
Figure 7. Root mean square deviations of the protein backbone grouped according to amino acid relative 
to (A) the starting structure (wild type murine protein pdb code 1AG2) and (B) compared to the average 
structure calculated for each protein. Solid line represents data from 2 replicate runs of the wildtype 
MoPrP; dotted line is MoPrP-S169N; dashed line is MoPrP-N173T; dot-dash line is MoPrP-S169N/N173T. 
Ramachandran plots of the ϕ –ψ dihedral angles of the backbone of the Ser/Asn169 amino acid for structures 
output over the course of molecular dynamics simulations of (C) MoPrP—structures output from both the 
previous and new simulations are used (D) MoPrP-S169N (E) MoPrP-N173T (F) MoPrP-S169N/N173T.
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susceptible to urea-based denaturation than recMoPrP and recMoPrP-N173T, whilst all 4 protein vari-
ants form unfolding intermediates at pH 4.0.
In all our in vitro experiments, recMoPrP-N173T behaved similarly to recMoPrP, whilst results 
for the other two proteins depend on the unfolding/misfolding pathway being studied. Coupled with 
our previous results27, the current results suggest that the different properties of recMoPrP-S169N and 
recMoPrP-S169N/N173T are caused partly by structural stability of the normal form of the protein. 
However, the actual amino acid sequence (as opposed to structure of the β 2–α 2 loop) clearly plays 
some role, probably by determining the detailed intra- or inter-molecular interactions during different 
unfolding or misfolding pathways.
Molecular dynamics simulations confirm low stability of MoPrP-S169N relative to other PrP 
variants. To understand, at an atomic level, the effect that each amino acid substitution has on the 
structure and stability of the normal form of PrP, we undertook molecular dynamics simulations on the 
wildtype protein (MoPrP) as well as proteins that we mutated in silico to include the substitutions S169N, 
N173T or both. Root mean square deviation of α -carbon atoms from either the starting structures or the 
average structure were calculated for each simulation and the results are shown in Fig. 7, panels (A) and 
(B). MoPrP, MoPrP-N173T and MoPrP-S169N/N173T show relatively small deviations from either the 
starting structure or average structure in many regions of the protein, although the loop regions joining 
areas of globular structure show the most dynamic excursions. By contrast, MoPrP-S169N has significant 
deviations from both its starting structure and average structure in several regions of the protein, most 
noticeably residues 134–164 and helix 3 (residues 204–214). This is suggestive of a decrease in stability 
of specific helical sections caused by the S169N mutation and such an effect was also observed during 
determination of the NMR structure of this protein26. These findings provide a structural rationale for 
the reduced thermal stability of recMoPrP-S169N relative to the other proteins studied.
Structural polymorphism in the β2-α2 loop backbone suggests that Tyr168 bonding may 
differentiate PrP isoforms. We next investigated the predicted structures of the β 2–α 2 loop regions 
of each of the proteins. Initially, we calculated the average structures over the course of the MD simula-
tions and noticed that the average structure of MoPrP differed somewhat from our previously published 
work27. Averaged structures from the four proteins studied here, alongside our previously-determined 
structure of MoPrP, are presented schematically in Supplementary Fig. 3. In all cases, the side chains of 
Arg163 and Phe174 occupy the intra-loop space, but other side chains also occupy this space to rather 
different extents for different proteins. For instance, in the average structures of the wildtype protein 
MoPrP and that of MoPrP-S169N/N173T, Asn170 protrudes from the loop and is predominately solvent 
exposed whereas in MoPrP-N173T, Asn170 is more hidden and is located near to Arg163.
We analysed the entire trajectory for each simulation to determine whether differences in average 
structures arose because proteins were stable and different across each simulation or because the struc-
tures alternated between one of several conformations but spent different lengths of time (on average) 
in one conformation relative to another. We calculated the dihedral angles of residues of the loop region 
using 1000 sets of coordinates that were output every 10 ps (for the wildtype simulations we combined 
structures from the analysis performed in this work with structures generated in previous work) and 
results are presented as Ramachandran plots in Supplementary Fig. 4. ϕ –ψ angles for residues 165 and 
166 are clustered around the archetypal “helical” area of the plot for all proteins, in line with NMR 
structures. However, ϕ –ψ angles for residues 165 and 167 occur in a bi-phasic distribution for MoPrP, 
MoPrP-S169N and MoPrP-N173T and these are consistent with residues 165–167 forming either a 3–10 
helix or a β -turn, as has previously been suggested24. The double mutant, MoPrP-S169N/N173T shows 
ϕ –ψ angles for residue 167 that correspond only to β -turn.
In contrast to residues 165–167, residues 169 and 170 (and to a lesser extent residue 168) sample a 
wider distribution of dihedral angles in each of the proteins. Ramachandran plots for these residues have 
several focal areas in which ϕ –ψ angles are concentrated, indicating that the backbone in this region is 
not inherently ‘flexible’ but can adopt more than one discrete conformation. The Ramachandran plots 
for residue Ser/Asn169 for each of the four protein variants are shown in Fig. 7 (C–F) and illustrate the 
polymorphic nature of the backbone in this loop region. ϕ –ψ angles for residue Ser169 of MoPrP are 
located around the helical area (ϕ ~ − 60, ψ ~ − 20), around the β -structure area (− 150, 150) but also in 
the left-handed helix area (60, 20). Residue 169 of the other protein variants also occupy similar areas of 
the plot, although for MoPrP-S169N the polyproline area (− 60, 120) is occupied at the expense of the 
β -structure area and the double mutant protein, MoPrP-S169N/N173T, does not occupy the left-handed 
helix area. Overall, these data indicate that residues 168–170 of each protein can adopt specific structures 
that are either elongated or partially helical and that the ensembles of different structures can be distin-
guished by the ϕ –ψ angles of residue 169, depicted on Fig. 7(C–F).
When one analyses the interactions of the amino acids in the loop region as a function of the ϕ –ψ 
angles of residue 169 there are only minor differences in the detailed interactions. However, a clear dif-
ference that stands out between protein variants is the proximity of Tyr168 to Phe174. In general, when 
residues 168–170 are in a turn-like conformation (residue 169 ϕ –ψ angles are − 80, 0) then the side chain 
of Tyr168 interacts with Phe174, through hydrophobic ring stacking, and the tyrosine hydroxyl interacts 
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with other polar side chains of the loop region. On the other hand, when residues 168–170 adopt a 
more elongated conformation (residue 169 ϕ –ψ angles in the β -structure region or α L region) the side 
chain of Tyr168 protrudes from the loop and is significantly more exposed to solvent. Interestingly, 
regardless of the ϕ –ψ angles of residue 169, in all structures of MoPrP-S169N/N173T Tyr168 does not 
interact with Phe174 and is excluded from the intra-loop region, probably as a direct result of interac-
tions between the side chains of Asn169 and Thr173. Supplementary Fig. 5 shows the distance between 
the Cζ atoms of Tyr168 and Phe174 as a function of the phi-psi angles for each of the protein struc-
tural ensembles, illustrating the dependence of backbone conformation on this interaction for MoPrP 
and MoPrP-S169N. For MoPrP-N173T, which segregates into two distinct conformations around resi-
due 169, interactions between Tyr168 and Phe174 appear to occur irrespective of residue 169 dihedral 
angles, suggesting that other bonding interactions in the intra-loop region are also stabilising the loop 
in this protein. Nevertheless, our data support a role for Tyr168-Phe174 ring stacking and exposure of 
the Tyr168 sidechain in mediating differential unfolding of PrP under particular denaturing conditions.
Discussion
There is a significant body of evidence that suggests that the β 2–α 2 loop plays a key role in the 
disease-associated misfolding of PrP during prion diseases21,33,34. Transgenic mice expressing murine 
PrPC with the substitutions S169N and N173T developed a spontaneous neurological disorder resem-
bling TSE disease35, and these substitutions also affected cross-species disease transmission15. The 
S169N/N173T substitutions were chosen because they produce a ‘rigid loop’ phenotype in PrPC, such 
that the loop region is structurally well defined in NMR studies (at 20 °C)23, whilst in non-‘rigid loop’ 
prion proteins, including the murine wildtype sequence, the loop conformation is ill-defined as a result 
of line-broadening during NMR measurements. Furthermore, a second line of transgenic mice overex-
pressing murine PrP with the D166S mutation, which causes the β 2–α 2 loop also to be well-defined, 
developed spontaneous disease16. Thus, it has been suggested that ‘rigid loop’ prion proteins may undergo 
misfolding more readily in vivo and that animals possessing ‘rigid loop’ PrPC may be more susceptible 
to TSE disease as a result. Deer, elk and bank voles are examples of animals possessing ‘rigid loop’ prion 
proteins that appear highly susceptible to disease; CWD infects cervids readily and bank voles have 
exceptionally short incubation periods to experimental prion infection. However, pigs, rabbits and horses 
also have ‘rigid loop’ prion proteins36–38 and these animals are believed to be rather resistant to TSE 
infections. In addition, transgenic mice expressing the entire elk prion sequence do not get spontaneous 
prion disease39,40 nor are they generally highly-susceptible to a range of TSE infections41,42. It remains 
uncertain, therefore, whether the ‘rigid loop’ phenotype is really the cause of increased susceptibility 
to TSE disease, or whether it is the specific amino acid alterations used to create ‘rigid loop’ PrPC that 
impact on the misfolding process. This controversy is compounded by recent suggestions that the pre-
vious interpretation of structural rigidity in the β 2–α 2 loop region is incorrect. The same authors who 
originally proposed this theory found that the presence of resonances from the β 2–α 2 loop is inversely 
temperature-dependent24. This suggests that prion proteins whose NMR spectra include resonances from 
the β 2–α 2 loop region may undergo extremely rapid inter-conversion between two discrete structures, 
whereas for those proteins that show peak broadening in resonances from this region the conformational 
exchange is slower. Hence, the ‘rigid loop’ PrPs may actually be conformationally more flexible than other 
PrP molecules, at least within the specific region of the β 2–α 2 loop24.
Protein
Rigid 
loop?
Fibril 
formation
Oligomer 
formation
Thermal 
denaturation
Urea-induced 
denaturation Molecular dynamics
recMoPrP No Rapid Slow Medium Stable
Loop region can adopt 
β -turn or 3–10 helix; 
Tyr168 can be either 
solvent exposed or 
protected
recMoPrP-S169N Yes Slow Rapid Less stable Less stable
Reduced overall 
stability; Loop region 
can adopt β -turn or 
3–10 helix; Tyr168 
can be either solvent 
exposed or protected
recMoPrP-N173T No Rapid Slow Medium Stable
Loop region can adopt 
β -turn or 3–10 helix; 
Tyr168 only solvent 
protected
recMoPrP-S169N/N173T Yes Slow
Very rapid 
and large 
oligomers 
formed
More stable Less stable
Loop region only 
adopts a β -turn; Tyr168 
only solvent exposed
Table 1. Summary of results from this work.
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Regardless of whether the ‘rigid loop’ phenotype is caused by increased structural rigidity or increased 
structural flexibility, the question of whether the ‘rigid loop’ phenotype causes misfolding in recombinant 
prion protein remains valid. The 4 proteins studied in this work produce different properties and our 
findings are summarised in Table 1. Compared to the wildtype recMoPrP, the ‘rigid loop’ prion protein 
recMoPrP-S169N/N173T was more stable to thermal denaturation, less stable to urea-induced denatura-
tion, oligomerised more readily but fibrillised less readily. Increased levels of oligomer formation are con-
sistent with an increased prevalence of misfolding caused by the ‘rigid loop’ and also agree with similar 
published studies18–20, whilst the finding that fibrillisation was inhibited further suggests that this specific 
misfolding pathway is of only tangential relevance to TSE disease28. Overall for recMoPrP-S169N/N173T, 
our findings conform to our previous suggestions that proteins that are more stable to thermal denatur-
ation also undergo disease-specific misfolding more readily27.
When we analysed the singly-mutated protein recMoPrP-N173T we found little difference in unfold-
ing or misfolding properties compared to the wildtype structure, suggesting that this mutation in iso-
lation is neutral in terms of protein structure. However, the S169N mutation in isolation caused more 
complex unfolding/misfolding properties and it is important to remember that, like the double mutant 
MoPrP-N169N/N173T, this protein also has the ‘rigid loop’ phenotype26. Compared to the wildtype pro-
tein, we found that recMoPrP-S169N was less stable to both thermal- and urea-induced denaturation, but 
that it oligomerised more rapidly and fibrillised less rapidly than recMoPrP. It therefore behaved similarly 
to recMoPrP-S169N/N173T but was less stable to thermal denaturation.
Based on our studies (Table 1) and other published work22,43, we can offer the following interpreta-
tions: (i) Both of the non-‘rigid loop’ proteins that differed only by the N173T substitution produced 
similar results, both experimentally and in silico, hence the N173T mutation in isolation does not dra-
matically affect murine PrPC structure or its misfolding pathways (ii) Both of the ‘rigid loop’ proteins that 
incorporated the S169N mutation fibrillised more slowly, oligomerised more rapidly and were less resist-
ant to urea-induced denaturation than wildtype recMoPrP, indicating a key role for either the S169N 
substitution or the ‘rigid loop’ phenotype in driving unfolding/misfolding, however (iii) co-substitution 
of S169N and N173T produced a protein that was thermally more stable than recMoPrP suggesting 
that the ‘rigid loop’ phenotype per se does not determine overall protein stability. Instead, the available 
evidence suggests that the S169N substitution aids misfolding by helping to expose Tyr168 and that this 
occurs independently of the over-riding conformation/stability of the backbone of residues 166–168. 
Hence, although MoPrP-S169N/N173T has a ‘rigid loop’ phenotype and is thermally more stable than 
MoPrP, the degree of solvent exposure of Tyr168 also increases the oligomerisation kinetics of this protein. 
It is of considerable interest that the side chain of Tyr168 forms important interactions during steric zipper 
formation of a synthetic peptide from the β 2-α 2 region. Indeed, it has been shown that a hydrophobic 
amino acid at this location in PrP is a pre-requisite for efficient disease transmission21, whilst alteration of 
this amino acid to a range of other, non-hydrophobic residues reduces prion protein conversion22. In con-
clusion, our data do not support a role for the ‘rigid loop’ phenotype in mediating all unfolding/misfolding 
pathways of PrP, but suggest a complex interplay between the effects of specific amino acid substitutions 
that are unfolding/misfolding pathway-dependent.
Experimental
Cloning of recombinant prion protein variants. Cloning and expression of recombinant murine 
PrP (recMoPrP) spanning residues 23–230 has previously been described44. Mutated mouse prion pro-
tein constructs were prepared by site-directed mutagenesis (QuikChange II Kit from Stratagene). The 
double mutant (recMoPrP-S169N/N173T) was created by sequentially modifying both amino acids 
through two rounds of site directed mutagenesis. All expression plasmids were transformed into Rosetta 
2 DE3 pLysS E. coli for protein expression and sequenced to confirm the presence of the appropriate 
nucleotide substitutions.
Protein expression and purification. The method of expression of recombinant protein followed 
that previously published27. For thermal denaturation monitored by circular dichroism, the methods for 
protein purification follow those described previously27 and involved sequential purification by immo-
bilised metal ion affinity chromatography (IMAC) followed by cation exchange chromatography under 
denaturing conditions. The final solution was dialysed extensively against 50 mM sodium acetate, pH 5.5, 
concentrated to ~1 mg/ml using centrifugal filtration and stored at − 80 °C prior to use.
For fibrillisation and oligomerisation assays the purification method has also previously been 
described in detail30,45. The purification involves IMAC chromatography under reducing conditions fol-
lowed by desalting on HiPrep 26/10 desalting column (GE Healthcare). The protein was further purified 
by HPLC using a reverse-phase column (214TP101522, Vydac), eluting the protein with a linear gradient 
from water to acetonitrile, acidified with 0.1% (v/v) trifluoroacetic acid. The protein was lyophilised in 
aliquots and stored at − 20 °C prior to use.
For urea-based denaturation studies monitored by circular dichroism, protein was purified according 
to published protocols32. Solubilised inclusion bodies were separated initially on a Sephacryl S-300 gel 
filtration column (Amersham Biosciences, Buckinghamshire, U.K.), and recPrP was further purified by 
reversed-phase HPLC. Purified protein was dialyzed against 5 mM MES, pH 5 and stored in aliquots at 
− 20 °C.
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For all experiments, appropriate protein aliquots were thawed prior to use and their concentration 
determined spectrophotometrically using molar extinction coefficients calculated according to the 
method of Gill and von Hippel46.
Thermal denaturation analysis by circular dichroism. The thermal stability assay of protein vari-
ants was performed and data processed as described previously27. Briefly, protein solutions were adjusted 
to 0.1 mg/ml and analysed by use of a Jasco J-710 spectropolarimeter. A sealed cuvette of 2 mm path 
length was heated from 20 °C to 90 °C. At each temperature point, 10 scans between 180–260 nm were 
taken and the reading at 222 nm was extracted. Multiple assays were performed for each protein variant, 
the data was normalised, averaged and fitted to a sigmoidal curve of the form x = M/(1 + r(a–T)), where ‘r’ 
is the rate of thermal denaturation in °C−1, ‘a’ is the midpoint of the transition, and ‘T’ is the temperature. 
‘M’ represents the maximum unfolded percentage.
Fibrillisation assay. Lyophilised recPrP was solubilised in 6 M guanidinium hydrochloride to a con-
centration of ~130 μ M. The fibrillisation reaction was set up as described previously29,30. Briefly, recPrP 
stock was added to fibrillisation buffer where the final concentration in the reaction consisted of 2 M 
guanidinium HCl, 0.01 M thiourea, 0.05 M 2-(N-Morpholino)ethanesulphonic acid (MES) pH 6.0, 10 μ M 
thioflavin T (ThT) and 5.2 μ M recPrP. 160 μ l of the reaction was added, per well, into a 96 well plate. For 
seeded fibrillisation assays, 1% (w/w protein) of homologous recPrP preformed into fibrils was added to 
the reaction mixture. Each well also contained three Teflon balls (3/32” diameter). The plate was con-
stantly shaken at 900 rpm, 37 °C for 24 hours and ThT fluorescence was measured every 5 minutes, with 
excitation at 444 nm and emission at 485 nm. The increase in ThT fluorescence was plotted against time 
and a sigmoidal curve fitted to the data. The lag time of the sigmoidal curve was calculated as described 
previously47.
Oligomerisation assay. The method to prepare oligomers from recPrP has been described before27,31. 
Lyophilised recPrP was solubilised in 20 mM sodium citrate, pH 3.4 buffer to a concentration of ~1 mg/ml 
and the protein was incubated at 45 °C for 2 hours. 15 μ l aliquots of protein were analysed by size-exclusion 
chromatography using a TSKgelG4000SWxl gel filtration column (Tosoh Bioscience) with 20 mM sodium 
citrate as a running buffer at a flow rate of 1 ml/min. The column calibration and the identification of 
peaks has been described previously27. Within each experimental replicate, the percent of each species 
was plotted against reaction time and theoretical lines of best fit were calculated by use of Matlab, cor-
responding to the theoretical reaction described in Supplementary Materials. This process yielded mul-
tiple determinations of the kinetic constants for oligomerisation of each protein studied and significant 
differences between each were tested using two-tailed, student’s t-test assuming unequal variances. For 
the plots in Fig.  4(E–H), the percent intensity of each species was averaged and a line of best fit was 
calculated for each set of averaged data.
Urea-based denaturation monitored by circular dichroism. Urea unfolding curves of recPrP 
variants were monitored by circular dichroism spectropolarimetry. For each experiment, folded and 
unfolded protein stocks were constructed in 8 M and 0 M urea respectively. At pH 7, samples were buff-
ered with 20 mM sodium phosphate whilst at pH 4 the buffer was 20 mM sodium acetate. To prepare 
samples with intermediate amounts of urea, the correct proportions of unfolded and folded stock solu-
tions were mixed.
The far-UV (190–260 nm) circular dichroism spectra were measured using JASCO J-815 spectropola-
rimeter by use of quartz cuvettes of path length 1 mm. A scanning rate of 100 nm/minute, time constant 
of one second, bandwidth of 1.0 nm, and resolution of 0.5 nm were used. Typically, 16 scans were aver-
aged per spectrum and buffer backgrounds were subtracted from the final spectra. The mean residue 
ellipticity at 222 nm wavelength was determined for each CD spectrum recorded and normalised to the 
fraction unfolded, with ellipticity values at 8 M urea corresponding to fully unfolded state and those at 
0 M urea to fully folded state.
Molecular dynamics. The atomic coordinates representing the murine prion protein, residues 124–226, 
were downloaded from the protein data bank (PDB identification code 1AG2)6. This structure was used 
as a starting point for simulations by use of the AMBER suite of molecular dynamics software (version 7) 
using the Amber99 forcefield48. Coordinates for mutated prion proteins were calculated by use of Swiss 
PDB Viewer, in each case the energetically most stable enantiomer was chosen. All starting structures 
were extensively energy minimised to remove energy hot spots, structures were equilibrated in silico 
to 37 °C and molecular dynamics was carried out at 37 °C for 10 ns. A Born approximation of implicit 
solvent was used to expedite simulations whilst a simulation of 200 mM salt was included to maintain 
buffering. Coordinates were output every 10 ps during each simulation for analysis. Molecular trajecto-
ries were analysed using AMBER software or with VMD analysis software49 and figures were built using 
VMD or MOLMOL50.
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